Lasa Supergenerics Ltd

Lasa Supergenerics Q1 2025 Results: Revenue Drops, Net Loss Widens Amid Fire Incident 🔥📉

- Revenue from Operations for Q1 2025: ₹2,001.18 lakhs (down from ₹3,083.55 lakhs in Q1 2024).

- Total Income for Q1 2025: ₹2,014.60 lakhs (vs. ₹3,084.02 lakhs in Q1 2024).

- Net Loss after tax for Q1 2025: ₹2,111.92 lakhs (vs. loss of ₹273.10 lakhs in Q1 2024).

- Fire incident on May 15, 2025, caused significant damage (₹1,200.02 lakhs to inventories, uninsured).

- Production halted at all units due to dependency on damaged Mother Unit; operations suspended.

- Management exploring contract manufacturing/leasing options for facility (pending approvals).

- Bank balance confirmations (₹7.99 lakhs) & fixed deposits (₹31.46 lakhs) unobtainable (dormant accounts).

- Single business segment: Active Pharmaceutical Ingredients (API).

- Auditor’s review flags fire impact & going concern concerns, but no other material misstatements found.